We are live on ! Find out more
BPA

Beacon Pointe Advisors Portfolio holdings

AUM $18.9B
1-Year Est. Return 18.9%
This Fund
S&P 500
This Quarter Est. Return
+8.97%
1 Year Est. Return
+18.9%
3 Year Est. Return
+65.33%
5 Year Est. Return
+77.81%
10 Year Est. Return
AUM
$5.16B
AUM Growth
+$686M
Cap. Flow
+$343M
Cap. Flow %
6.66%
Top 10 Hldgs %
22.72%
Holding
1,125
New
131
Increased
509
Reduced
372
Closed
65

Sector Composition

Rank Sector Weight
1 Technology 11.75%
2 Healthcare 7.31%
3 Financials 6.66%
4 Consumer Discretionary 4.68%
5 Industrials 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RITM icon
1026
Rithm Capital
RITM
$5.18B
$86K ﹤0.01%
10,529
-2,930
-22% -$24.5K
GGN
1027
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$764M
$83.5K ﹤0.01%
23,003
-674
-3% -$2.35K
EXG icon
1028
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.92B
$81.7K ﹤0.01%
+10,825
New +$82.9K
JFIN
1029
Jiayin Group
JFIN
$114M
$81.1K ﹤0.01%
35,282
QS icon
1030
QuantumScape Corp
QS
$3.16B
$78.4K ﹤0.01%
13,820
-5,502
-28% -$40.7K
LCID icon
1031
Lucid Motors
LCID
$2.51B
$74.8K ﹤0.01%
1,095
-19
-2% -$2.09K
JPS
1032
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$74.1K ﹤0.01%
10,900
-561
-5% -$3.83K
APLD icon
1033
Applied Digital
APLD
$7.59B
$73.5K ﹤0.01%
+39,939
New +$78.7K
PTRA
1034
DELISTED
Proterra Inc. Common Stock
PTRA
$71.9K ﹤0.01%
19,060
ERIC icon
1035
Ericsson
ERIC
$31.6B
$71.6K ﹤0.01%
12,254
+54
+0.4% +$325
PFN
1036
PIMCO Income Strategy Fund II
PFN
$693M
$70.7K ﹤0.01%
10,000
-1,000
-9% -$7.25K
SIRI icon
1037
SiriusXM
SIRI
$10.6B
$63.4K ﹤0.01%
1,086
+1
+0.1% +$61
ADMA icon
1038
ADMA Biologics
ADMA
$1.98B
$58K ﹤0.01%
14,960
AQST icon
1039
Aquestive Therapeutics
AQST
$473M
$54.1K ﹤0.01%
60,000
LYG icon
1040
Lloyds Banking Group
LYG
$88.7B
$52.9K ﹤0.01%
24,050
-477
-2% -$981
CRMD icon
1041
CorMedix
CRMD
$605M
$46.4K ﹤0.01%
11,000
SAN icon
1042
Banco Santander
SAN
$199B
$38.8K ﹤0.01%
13,149
+2,050
+18% +$5.59K
DHF
1043
BNY Mellon High Yield Strategies Fund
DHF
$171M
$37.8K ﹤0.01%
+17,498
New +$38.7K
ATRA icon
1044
Atara Biotherapeutics
ATRA
$71.2M
$36.1K ﹤0.01%
+440
New +$45.9K
NVTS icon
1045
Navitas Semiconductor
NVTS
$2.76B
$35.2K ﹤0.01%
10,029
GLS
1046
DELISTED
Gelesis Holdings, Inc.
GLS
$34.6K ﹤0.01%
119,149
KG
1047
Kestrel Group
KG
$70.5M
$31.6K ﹤0.01%
+750
New +$31.9K
CUE icon
1048
Cue Biopharma
CUE
$139M
$28.5K ﹤0.01%
+333
New +$30.5K
TRAW icon
1049
Traws Pharma
TRAW
$7.31M
$25.4K ﹤0.01%
1,574
-384
-20% -$7.24K
QUBT icon
1050
Quantum Computing Inc
QUBT
$1.78B
$24.2K ﹤0.01%
+16,000
New +$32.5K

Similar funds

Beacon Pointe Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Beacon Pointe Advisors held 1,125 positions worth $5.16B, up 15% from $4.47B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Beacon Pointe Advisors deployed $343M of net new capital in Q4 2022, opening 131 new positions and adding to 509 existing holdings. Its largest new stake was Sabine Royalty Trust: 130,900 shares worth $11.2M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard Intermediate-Term Corporate Bond ETF, an estimated $5.33M trimmed.

  • Beacon Pointe Advisors's largest Q4 2022 buy was Sabine Royalty Trust: 130,900 shares worth $11.2M.
  • Beacon Pointe Advisors added most to iShares National Muni Bond ETF in Q4 2022, an estimated $27.3M increase.
  • Beacon Pointe Advisors's biggest Q4 2022 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $5.33M.
  • Beacon Pointe Advisors fully exited Target in Q4 2022, selling an estimated $8.61M.
  • Beacon Pointe Advisors's ten largest holdings make up 23% of its $5.16B portfolio in Q4 2022.
  • Beacon Pointe Advisors opened 131 new positions and closed 65 in Q4 2022.
  • Beacon Pointe Advisors's portfolio value rose 15% quarter-over-quarter to $5.16B.

Based on Beacon Pointe Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.